227 related articles for article (PubMed ID: 30168250)
1. Reasonable two-stage adaptive designs for single-arm phase II clinical trials.
Kashiwabara K; Matsuyama Y
Pharm Stat; 2018 Nov; 17(6):770-780. PubMed ID: 30168250
[TBL] [Abstract][Full Text] [Related]
2. Optimal adaptive two-stage designs for phase II cancer clinical trials.
Englert S; Kieser M
Biom J; 2013 Nov; 55(6):955-68. PubMed ID: 23868324
[TBL] [Abstract][Full Text] [Related]
3. Optimal adaptive two-stage designs for early phase II clinical trials.
Shan G; Wilding GE; Hutson AD; Gerstenberger S
Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
[TBL] [Abstract][Full Text] [Related]
4. Adaptive two-stage designs in phase II clinical trials.
Banerjee A; Tsiatis AA
Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
[TBL] [Abstract][Full Text] [Related]
5. Minimax and admissible adaptive two-stage designs in phase II clinical trials.
Shan G; Zhang H; Jiang T
BMC Med Res Methodol; 2016 Aug; 16():90. PubMed ID: 27485595
[TBL] [Abstract][Full Text] [Related]
6. Optimal futility stopping boundaries for binary endpoints.
Freitag MM; Li X; Rauch G
BMC Med Res Methodol; 2024 Mar; 24(1):80. PubMed ID: 38539108
[TBL] [Abstract][Full Text] [Related]
7. Modified Simon's minimax and optimal two-stage designs for single-arm phase II cancer clinical trials.
Kim J; Schell MJ
Oncotarget; 2019 Jul; 10(42):4255-4261. PubMed ID: 31303960
[TBL] [Abstract][Full Text] [Related]
8. A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.
Jin H; Wei Z
Contemp Clin Trials; 2012 Nov; 33(6):1255-60. PubMed ID: 22772088
[TBL] [Abstract][Full Text] [Related]
9. Optimal three-stage designs for phase II cancer clinical trials.
Chen TT
Stat Med; 1997 Dec; 16(23):2701-11. PubMed ID: 9421870
[TBL] [Abstract][Full Text] [Related]
10. An optimal three-stage design for phase II clinical trials.
Ensign LG; Gehan EA; Kamen DS; Thall PF
Stat Med; 1994 Sep; 13(17):1727-36. PubMed ID: 7997706
[TBL] [Abstract][Full Text] [Related]
11. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
12. Optimal, minimax and admissible two-stage design for phase II oncology clinical trials.
Qin F; Wu J; Chen F; Wei Y; Zhao Y; Jiang Z; Bai J; Yu H
BMC Med Res Methodol; 2020 May; 20(1):126. PubMed ID: 32434577
[TBL] [Abstract][Full Text] [Related]
13. Spatial Two-stage Designs for Phase II Clinical Trials.
Kim S; Wong WK
Comput Stat Data Anal; 2022 May; 169():. PubMed ID: 35058669
[TBL] [Abstract][Full Text] [Related]
14. Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.
Zhao J; Yu M; Feng XP
BMC Med Res Methodol; 2015 Jun; 15():48. PubMed ID: 26048655
[TBL] [Abstract][Full Text] [Related]
15. Optimal two-stage randomized phase II clinical trials.
Logan BR
Clin Trials; 2005; 2(1):5-12. PubMed ID: 16279574
[TBL] [Abstract][Full Text] [Related]
16. Extended two-stage adaptive designs with three target responses for phase II clinical trials.
Kim S; Wong WK
Stat Methods Med Res; 2018 Dec; 27(12):3628-3642. PubMed ID: 28535716
[TBL] [Abstract][Full Text] [Related]
17. On Simon's two-stage design for single-arm phase IIA cancer clinical trials under beta-binomial distribution.
Liu J; Lin Y; Shih WJ
Stat Med; 2010 May; 29(10):1084-95. PubMed ID: 20077506
[TBL] [Abstract][Full Text] [Related]
18. Balanced two-stage designs for phase II clinical trials.
Ye F; Shyr Y
Clin Trials; 2007; 4(5):514-24. PubMed ID: 17942467
[TBL] [Abstract][Full Text] [Related]
19. Re-formulating Gehan's design as a flexible two-stage single-arm trial.
Grayling MJ; Mander AP
BMC Med Res Methodol; 2019 Jan; 19(1):22. PubMed ID: 30691398
[TBL] [Abstract][Full Text] [Related]
20. Optimal two-stage designs for single-arm phase II oncology trials with two binary endpoints.
Kunz CU; Kieser M
Methods Inf Med; 2011; 50(4):372-7. PubMed ID: 21057719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
